Global costs of Plasmodium vivax malaria estimated for the first time
At-the-moment stress for parents during COVID-19 stay-at-home restrictions
1 June 2021Researchers develop proof-of-concept treatment that elevates adult and fetal hemoglobin
1 June 2021Global costs of Plasmodium vivax malaria estimated for the first time
Plasmodium vivax malaria is a mosquito-borne illness that causes significant morbidity. However, the household and healthcare provider costs of the disease are unknown. A new study published in the open-access journal PLOS Medicine by Dr. Angela Devine at Menzies School of Health Research in Australia, and colleagues estimate the global economic burden of P. vivax for the first time using country-level data.
